Outcome of adult acute lymphoblastic leukaemia following induction chemotherapy with modified MRC UKALL XII/ECOG E2993 protocol

Authors

  • N Islam Department of Haematology, National Institute of Cancer Research and Hospital (NICRH), Dhaka
  • MM Rahman Department of Haematology, National Institute of Cancer Research and Hospital (NICRH), Dhaka
  • MA Aziz Department of Haematology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka
  • F Begum Department of Haematology, National Institute of Cancer Research and Hospital (NICRH), Dhaka
  • ABM Yunus Department of Haematology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka

DOI:

https://doi.org/10.3329/bmrcb.v38i2.12879

Keywords:

Induction chemotherapy

Abstract

Cure rates for adult acute lymphoblastic leukaemia (ALL) in developing countries are significantly lower because of problems unique to these countries. Recent studies have reported complete response rates for any induction regimen of more than 90% in adult ALL patients. This study was conducted to evaluate the response rate of induction chemotherapy in adult ALL patients in the Department of Haematology, Bangabandhu Sheikh Mujib Medical University, from January 2007 to December 2008.  In this observational study, 35 newly diagnosed ALL patients classified either as L1/L2 according to  French-American-British (FAB) classification, aged between 15 to 60 years were assigned for  induction therapy with modified MRC UKALL XII/ECOG E2993 protocol. But ultimately 30 patients completed therapy and available for statistical analysis. Among the studied 30 cases 12(40%) patients after phase 1 and overall 24(80%) patients after phase 2 induction therapy, achieved morphologic complete remission (CR). After phase 2 therapy 6(20%) patients fell in the group of non responders (NR) as the blast percentage was ?5% at the time of bone marrow evaluation. This study shows the response rates in adult ALL with induction therapy slightly below the anticipated response rates of developed countries which may be due to little modification of the original protocol.

DOI: http://dx.doi.org/10.3329/bmrcb.v38i2.12879

Bangladesh Med Res Counc Bull 2012; 38: 43-46

Downloads

Download data is not yet available.
Abstract
90
PDF
258

Downloads

Published

2012-12-09

How to Cite

Islam, N., Rahman, M., Aziz, M., Begum, F., & Yunus, A. (2012). Outcome of adult acute lymphoblastic leukaemia following induction chemotherapy with modified MRC UKALL XII/ECOG E2993 protocol. Bangladesh Medical Research Council Bulletin, 38(2), 43–46. https://doi.org/10.3329/bmrcb.v38i2.12879

Issue

Vol. 38 No. 2 (2012)

Section

Research Papers

License

Authors who publish with this journal agree to the following terms.

Authors retain copyright and grant the journal right of first publication.

Creative Commons Licence
Articles in the Bangladesh Medical Research Council Bulletin are licensed under a Creative Commons Attribution 4.0 International License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).